ARQT
Arcutis Biotherapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$33.48
+4.61%Forward multiples
Based on analyst estimates
- P/E forward
- 38.97x
- P/E 2026E
- 67.50x
- P/E 2027E
- 24.69x
- P/E 2028E
- 15.52x
- P/S forward
- 6.61x
Trailing multiples
Trailing twelve months
- P/E TTM
- 151.62x
- PEG TTM
- 0.51x
- Price / book
- 19.08x
- Price / sales
- 9.07x
- Price / cash flow
- 107.04x
Enterprise value
- Enterprise value
- $4.1B
- EV / sales
- 8.80x
- EV / EBITDA
- 94.02x
- EV / EBIT
- 119.21x
- Market cap
- $4.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026